OCM
IONS icon

One Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

One Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43M Buy
58,939
+12,818
+28% +$1.01M 0.12% 137
2025
Q4 		$3.65M Buy
46,121
+9,695
+27% +$730K 0.11% 130
2025
Q3 		$2.38M Buy
36,426
+6,561
+22% +$320K 0.08% 145
2025
Q2 		$1.18M Buy
+29,865
New +$977K 0.04% 196
2014
Q4 		– Sell
-2,000
Closed -$78K – 303
2014
Q3 		$78K Buy
+2,000
New +$70.9K 0.03% 194

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

One Capital Management's IONS Position: Q1 2026 in Review

One Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 28% in Q1 2026, buying an estimated $1.01M and bringing the position to 58,939 shares worth $4.43M. The position accounts for 0.12% of the portfolio, ranked #137.

One Capital Management first reported a position in IONS in Q3 2014 and has held it in 5 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • One Capital Management held 58,939 shares of Ionis Pharmaceuticals worth $4.43M as of Q1 2026.
  • One Capital Management bought 12,818 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.01M.
  • Ionis Pharmaceuticals made up 0.12% of One Capital Management's portfolio in Q1 2026, its #137 holding.
  • One Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2014 and has held it in 5 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.